Stock Price
11.03
Daily Change
0.10 0.87%
Monthly
9.26%
Yearly
-45.37%
Q3 Forecast
10.46

EPS Reference Time Actual Consensus Previous
2026-10-29 FY2026Q3 0.12 0.09
2026-07-30 FY2026Q2 0.22 0.22
2026-05-05 FY2026Q1 0.20 0.08 0.19
2026-03-04 FY2025Q4 0.23 0.23 0.25
2025-10-29 FY2025Q3 0.09 0.13 0.13



Peers Price Chg Day Year Date
Amplifon 11.03 0.10 0.87% -45.37% Jul/24
Avanos Medical 24.99 0.01 0.04% 108.08% Jul/24
Brookdale Senior Living 15.15 0.65 4.45% 101.66% Jul/24
Cencora 309.89 4.83 1.58% 6.73% Jul/24
Diasorin 66.74 -0.08 -0.12% -26.25% Jul/24
Encompass Health 112.89 1.83 1.65% 4.85% Jul/24
Enovis 27.03 0.97 3.72% -1.85% Jul/24
GE HealthCare Technologies 60.59 -1.40 -2.26% -21.93% Jul/24
Pediatrix Medical Group 26.26 0.68 2.66% 22.31% Jul/24
Veradigm 5.14 0.34 7.08% 6.42% Jul/23

Indexes Price Day Year Date
IT40 51802 486.39 0.95% 27.20% Jul/24
EU600 645 5.25 0.82% 17.20% Jul/24

Amplifon traded at 11.03 this Friday July 24th, increasing 0.10 or 0.87 percent since the previous trading session. Looking back, over the last four weeks, Amplifon gained 9.26 percent. Over the last 12 months, its price fell by 45.37 percent. Looking ahead, we forecast Amplifon to be priced at 10.46 by the end of this quarter and at 9.65 in one year, according to Trading Economics global macro models projections and analysts expectations.

Amplifon SpA is an Italy-based company active in the hearing care retail market. The Company provides personalized solutions and customer care to hearing-impaired people. It offers a wide range of services from diagnosing hearing difficulties, to fitting, servicing and maintaining hearing aids. The Company is organized in three geographical operating segments: Europe, Middle East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Ireland, Spain, Portugal, Switzerland, Belgium, Luxemburg, Hungary, Egypt, Turkey, Poland and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama and Mexico) and Asia-Pacific (Australia, New Zealand, India and China).